'J urol' presentation slideshows

Sc Urologia Italian Germ-cell cancer Study Group

Mediterranean School of Oncology. Highlights in the Management of Urogenital Cancer Rome, May 9-10, 2008. Controversies in treatment and surveillance of clinical stage I seminoma and nonseminoma testis cancer Nicola Nicolai, Milan. Sc Urologia Italian Germ-cell cancer Study Group.

973 views • 78 slides

Renovascular Disease recognition and management

Renovascular Disease recognition and management. Craig A. Thompson, M.D., MMSc. Cardiac and Vascular Interventional Services Dartmouth Hitchcock Medical Center Lebanon, NH. When to When not to In whom. Renovascular Disease: The Clinical Perspective. Old Medical Adage :

1.04k views • 72 slides

High-grade Prostatic Intraepithelial Neoplasia on Needle Biopsy Risk of Cancer on Repeat Biopsy Related to Number of I

High-grade Prostatic Intraepithelial Neoplasia on Needle Biopsy Risk of Cancer on Repeat Biopsy Related to Number of Involved Cores and Morphologic Pattern. Tarek Bishara, MD,* Dharam M. Ramnani, MD , ? Jonathan I. Epstein, MD.

976 views • 47 slides

Radical Nephrectomy The Role Of Surgery In mRCC

Radical Nephrectomy The Role Of Surgery In mRCC Peter Mulders Professor and Chairman Department of Urology University Medical Center Nijmegen The Netherlands Renal Cell Carcinoma General Aspects RCC accounts for 3% of all adult tumors 100.000 deaths from RCC every year worldwide

2.41k views • 39 slides

Understanding P-values and Confidence Intervals

Understanding P-values and Confidence Intervals. Thomas B. Newman, MD, MPH. 20 Nov 08. Announcements. Optional reading about P-values and Confidence Intervals on the website Exam questions due Monday 11/24/08 5:00 PM Next week (11/27) is Thanksgiving

1.32k views • 37 slides

Evaluation and Management of Nonobstructive Azoospermia

1.09k views • 31 slides

Uracyst

Uracyst. A summary of the rationale and clinical evidence. Abbreviated Prescribing Information can be found on the last slide of this presentation. PMR-NOV-2010-0615 Date of Preparation: November 2010. . Uracyst . 2% solution of sodium chondroitin sulfate Medical device

596 views • 26 slides

Mechanism of Action Combidex in MR Imaging

Mechanism of Action Combidex in MR Imaging. Mukesh Harisinghani, MD Department of Radiology, Massachusetts General Hospital. Overview. Current limitations for LN staging in cancer Combidex enhanced MRI Mechanism of action

750 views • 21 slides

Unequal Utilization of New Technologies by Race The Use of New Prostate Surgeries (TUNA and TUMT) among Medicare Elderly

Unequal Utilization of New Technologies by Race The Use of New Prostate Surgeries (TUNA and TUMT) among Medicare Elderly Beneficiaries. Xinhua Yu, PhD, MBBS A. Marshall McBean, MD, MSc Debra S. Caldwell, MS Research Data Assistance Center University of Minnesota Janet A. Anderson

338 views • 18 slides

A Few Salient Points About: Pediatric UTIs

316 views • 16 slides

Atypical Renal Cysts

672 views • 10 slides

Introducing a new and simple scoring system to evaluate oncological and functional outcome after radical prostatectomy

120. 100. 80. 60. 40. 20. 0. 0. 1. 2. 3. 4. 5. 6. 7. Abstract. Score. Definition. Introducing a new and simple scoring system to evaluate oncological and functional outcome after radical prostatectomy

122 views • 1 slides

Post-TRUS sepsis: Targeted use of prophylactic ertapenem for high-risk patients

No. 078. Post-TRUS sepsis: Targeted use of prophylactic ertapenem for high-risk patients. Giovanni Losco, Rod Studd Department of Urology, Wellington Regional Hospital, Wellington, New Zealand. Posters Proudly Supported by: . Introduction

204 views • 1 slides

American Urological Association Symptom Index for Assessing LUTS Associated With BPH

American Urological Association Symptom Index for Assessing LUTS Associated With BPH. Over the past month, how often have you Had a sensation of not emptying your bladder completely after you finished urinating? Had to urinate again less than 2 hours after you finished urinating?

330 views • 1 slides